Yoshihiko Hirohashi Selected Research

Yoshihiko Hirohashi Research Topics

Disease

146	Neoplasms (Cancer) 05/2024 - 05/2002
19	Carcinoma (Carcinomatosis) 07/2023 - 05/2006
14	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 06/2004
13	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2013
11	Breast Neoplasms (Breast Cancer) 11/2023 - 02/2005
11	Colonic Neoplasms (Colon Cancer) 09/2023 - 10/2005
11	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 07/2007
11	Lung Neoplasms (Lung Cancer) 01/2019 - 02/2005
10	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 01/2016
8	Osteosarcoma (Osteogenic Sarcoma) 10/2023 - 01/2003
8	Testicular Neoplasms (Testicular Cancer) 01/2023 - 06/2012
7	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 12/2009
7	Melanoma (Melanoma, Malignant) 12/2023 - 02/2005
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2023 - 02/2012
6	Hypoxia (Hypoxemia) 08/2020 - 11/2009
6	Adenocarcinoma 08/2020 - 02/2005
5	Mouth Neoplasms (Oral Cancer) 12/2023 - 01/2009
5	Squamous Cell Carcinoma of Head and Neck 09/2023 - 08/2002
5	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023 - 05/2006
5	Carcinogenesis 01/2021 - 02/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 01/2017
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2019 - 05/2003
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2011 - 08/2002
3	Adenocarcinoma of Lung 01/2023 - 01/2013
3	Tuberculosis (Tuberculoses) 03/2021 - 10/2007
3	Ovarian Neoplasms (Ovarian Cancer) 05/2016 - 01/2013
3	Tics (Tic) 08/2013 - 03/2010
2	Stomach Neoplasms (Stomach Cancer) 05/2024 - 02/2005
2	Granuloma 06/2023 - 03/2021
2	Infections 04/2023 - 10/2007
2	Microsatellite Instability 01/2022 - 01/2017
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Kidney Neoplasms (Kidney Cancer) 03/2018 - 12/2017
2	Neuroblastoma 10/2016 - 01/2004

Drug/Important Bio-Agent (IBA)

54	AntigensIBA 10/2023 - 05/2002
53	Peptides (Polypeptides)IBA 05/2024 - 05/2002
33	Proteins (Proteins, Gene)FDA Link 05/2024 - 06/2002
22	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2016
19	SurvivinIBA 02/2020 - 06/2002
16	HLA Antigens (Human Leukocyte Antigens)IBA 05/2024 - 08/2006
11	HLA-A24 AntigenIBA 10/2020 - 07/2002
10	Protein Subunit VaccinesIBA 08/2019 - 06/2004
9	EpitopesIBA 01/2018 - 06/2002
9	Cancer VaccinesIBA 01/2014 - 05/2002
7	Aldehyde Dehydrogenase 1 FamilyIBA 01/2022 - 10/2012
6	Complementary DNA (cDNA)IBA 10/2023 - 08/2004
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 06/2009
6	Messenger RNA (mRNA)IBA 01/2020 - 08/2009
6	Inhibitor of Apoptosis ProteinsIBA 02/2011 - 02/2005
5	Aldehyde DehydrogenaseIBA 05/2024 - 07/2012
5	Neoplasm Antigens (Tumor Antigens)IBA 06/2023 - 05/2003
5	Small Interfering RNA (siRNA)IBA 04/2023 - 10/2005
4	B7-H1 AntigenIBA 12/2023 - 04/2017
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2023 - 01/2016
4	NivolumabIBA 07/2021 - 01/2019
4	Monoclonal AntibodiesIBA 04/2018 - 06/2009
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2018 - 04/2011
4	Oxidoreductases (Dehydrogenase)IBA 04/2017 - 05/2015
4	Histocompatibility Antigens Class IIBA 01/2017 - 01/2015
4	VaccinesIBA 02/2016 - 04/2009
4	AutoantibodiesIBA 05/2011 - 05/2005
3	AldehydesIBA 05/2024 - 01/2013
3	ParaffinIBA 10/2023 - 12/2009
3	Formaldehyde (Formol)FDA Link 10/2023 - 05/2012
3	Transcription Factors (Transcription Factor)IBA 04/2023 - 08/2011
3	Immune Checkpoint ProteinsIBA 04/2023 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2004
3	RecoverinIBA 01/2023 - 07/2002
3	LigandsIBA 11/2021 - 01/2014
3	incomplete Freund's adjuvantIBA 02/2020 - 06/2011
3	Phosphotransferases (Kinase)IBA 10/2017 - 12/2005
3	Coloring Agents (Dyes)IBA 10/2013 - 04/2011
3	HLA-A Antigens (HLA-A)IBA 02/2005 - 05/2002
2	Calcibiotic Root Canal SealerIBA 04/2024 - 01/2017
2	Odorant Receptors (Odorant Receptor)IBA 09/2023 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 07/2023 - 01/2023
2	Interferon-gamma (Interferon, gamma)IBA 06/2023 - 10/2007
2	Differentiation AntigensIBA 04/2023 - 01/2023
2	MicroRNAs (MicroRNA)IBA 03/2023 - 10/2015
2	Therapeutic UsesIBA 05/2022 - 08/2006
2	pembrolizumabIBA 07/2021 - 11/2020
2	Photosensitizing Agents (Photosensitizers)IBA 02/2021 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2021 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 10/2017
2	EnzymesIBA 08/2020 - 05/2015
2	Interferon-alpha (Interferon Alfa)IBA 02/2020 - 01/2013
2	Gemcitabine FDA Link 08/2019 - 10/2018
2	AcidsIBA 01/2019 - 05/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2016
2	HSP40 Heat-Shock ProteinsIBA 10/2016 - 01/2016
2	Oxygen (Dioxygen)IBA 04/2016 - 11/2009
2	CytokinesIBA 01/2016 - 05/2003
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2015 - 04/2013

Therapy/Procedure

61	Immunotherapy 05/2024 - 05/2002
44	Therapeutics 10/2023 - 06/2004
23	Drug Therapy (Chemotherapy) 05/2024 - 08/2004
18	Radiotherapy 05/2024 - 03/2010
6	Chemoradiotherapy 12/2023 - 08/2013
3	Aftercare (After-Treatment) 03/2021 - 01/2013
2	Nephrectomy 03/2020 - 05/2011